IgAC2:

Zi Wang1,2,3, Xujie Zhou4,5,6, Sufang Shi4,5,6

  • 1Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China, tonypedia@126.com.

PubMed
概括

患有C2病变的IgA脏病 (IgAN) 患者的预后不佳. 平均动脉压,eGFR和T2病变预测末期病 (ESKD) 风险,突出显示需要新的治疗方法.